REFERENCES
- Cossu G, Mereu A, Deriu M, et al. Prevalence of primary blepharospasm in Sardinia, Italy: A service-based survey. Mov Disord 2006;21:2005–2008.
- Hallett M, Evinger C, Jankovic J, Stacy M. BEBRF International Workshop: Update on blepharospasm: Report from the BEBRF International Workshop. Neurology 2008;71:1275–1282.
- Bartolomé FM, Fanjul S, Cantarero S, Hernández J, García Ruiz PJ. Distonías focales primarias: Estudio descriptivo de 205 pacientes [English translation]. Neurologia. 2003;18:59–65.
- Nutt JG, Muenter MD, Aronson A, Kurland LT, Melton LJ. Epi-demiology of focal and generalized dystonia in Rochester, Minnesota. Mov Disord 1988;3:188–194.
- Nakashima K, Kusumi M, Inoue Y, Takahashi K. Prevalence of focal dystonias in the western area of Tottori prefecture in Japan. Mov Disord 1995;4:440–443.
- Defazio G, Livrea P, De Salvia R, Manobianca G, Coviello V, Anaclerio D, Guerra V, Martino D, Valluzzi F, Liguori R, Logro-scino G. Prevalence of primary blepharospasm in a community of Puglia region, Southern Italy. Neurology 2001;56:1579–1581.
- Defazio G, Abbruzzese G, Aniello MS, et al. Eye symptoms in relatives of patients with primary adult-onset dystonia. Mov Disord 2012;27:305–307.
- Park DI, Shin HM, Lee SY, Lew H. Tear production and drainage after botulinum toxin A injection in patients with essential blepharospasm. Acta Ophthalmol 2013;91:e108–e112.
- Horwath-Winter J, Bergloeff J, Floegel I, Haller-Schober EM, Schmut O. Botulinum toxin A treatment in patients suffering from blepharospasm and dry eye. Br J Ophthalmol 2003;87:54–56.
- Costa PG, Cardoso IP, Saraiva FP, Raiza AC, Tanaka LK, Matayoshi S. Lacrimal film evaluation of patients with facial dystonia during botulinum toxin type A treatment [English translation]. Arq Bras Oftalmol 2006;69:319–322.
- Hurwitz JJ, Kazdan M, Codere F, Pashby RC. The orbicularis stripping operation for intractable blepharospasm: Surgical results in eighteen patients. Can J Ophthalmol. 1986;21:167–169.
- Harvey HK. Resection of the facial nerve for blepharospasm. Arch Ophthalmol. 1971 Aug;86(2):178–181.
- The Dry Eye Workshop Group. The definition and classification of dry eye disease: Report of the Definition and Classification Subcommittee of the International Dry Eye WorkShop. Ocul Surf. 2007;5:75–92.
- Jankovic J, Havins WE, Wilkins RB. Blinking and blepharospasm: Mechanism, diagnosis, and management. JAMA 1982;248:3160–3164.
- Henderson JW. Essential blepharospasm. Trans Am Ophthalmol Soc 1956;54:453–520.
- Kenney C, Jankovic J. Botulinum toxin in the treatment of blepharospasm and hemifacial spasm. J Neural Transm 2008;115:585–591.
- Kraft SP, Lang AE. Cranial dystonia, blepharospasm and hemifacial spasm: Clinical features and treatment, including the use of botulinum toxin. CMAJ 1988;139:837–844.
- Auger RG, Whisnant JP. Hemifacial spasm in Rochester and Olmsted County, Minnesota, 1960 to 1984. Arch Neurol 1990;47:1233–1234.
- Jitpimolmard S, Tiamkao S, Laopaiboon M. Long-term results of botulinum toxin type A (Dysport) in the treatment of hemifacial spasm: A report of 175 cases. J Neurol Neurosurg Psychiatry 1998;64:751–757.
- Elston JS, Marsden CD, Grandas F, Quinn NP. The significance of ophthalmological symptoms in idiopathic blepharospasm. Eye (Lond) 1988;2:435–439.
- Grandas F, Elston J, Quinn N, Marsden CD. Blepharospasm: A review of 264 patients. J Neurol Neurosurg Psychiatry 1988;51:767–772.
- Tsubota K, Hata S, Okusawa Y, et al. Quantitative videographic analysis of blinking in normal subjects and patients with dry eye. Arch Ophthalmol 1996;114:715–720.
- Doane MG. Blinking and the mechanics of the lacrimal drainage system. Ophthalmology 1996;88:844–845.
- Blasi J, Chapman ER, Link E. Botulinum neurotoxin A selectively cleaves the synaptic protein SNAP-25. Nature 1993;365:160–163.
- Spiera H, Asbell PA, Simpson DM. Botulinum toxin increases tearing in patients with Sjögren‘s syndrome: A preliminary report. J Rheumatol 1997;24:1842–1843.
- Price J, O’Day J. A comparative study of tear secretion in blepharospasm and hemifacial spasm patients treated with botulinum toxin. J Clin Neuroophthalmol 1993;13:67–71.
- Sahlin S, Chen E. Evaluation of the lacrimal drainage function by the drop test. Am J Ophthalmol 1996;122:701–708.